Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial

Summary

In patients with subclinical coronary artery disease, the ASCAD-P study aims to assess the feasibility of a larger phase 3 pragmatic randomized controlled trial comparing prescription versus no prescription of low-dose aspirin in routine clinical practice.

Timeline

Start

2026-05-01

Primary completion

2027-05-01

Completion

2028-05-01

Drugs

Indications